successfully combined 3-AQ, CHCA, and ammonium dihydrogen phosphate (ADP) as a solidified ILM for MALDI-MS analysis of phosphopeptides
Sacc SC, Roszkowska AM, Izzotti A
Despite the wealthy research regarding B12 and PA, doctors will often refuse to prescribe more than one shot every few months
If passed, TROA would: Permanently allow Medicare Part D to cover FDA-approved anti-obesity medications Expand Medicare Part B coverage of intensive behavioral therapy for obesity to include a wider range of providers (not just primary care physicians) However, in April 2025, CMS announced it would not include Medicare Part D coverage of obesity drugs in its rule changes for 2026, stating the proposal was "not appropriate at this time." That decision pushed the issue back to Congress, where the TROA remains under consideration
From oral GLP-1s to triple agonists, each molecule represents a shift in how we define access, efficacy, and patient-centric innovation
Ando 2015)